Is it time for geriatricians to get on board with lecanemab? Jason Karlawish and Ken Covinsky
GeriPal
DECEMBER 15, 2022
In an article in the NEJM (a published article this time, wonder of wonders!) You would love this because in that story that was in that patient CHR was a particular song that had meant a lot to this individual. But wait, there’s a shiny new anti-amyloid drug, lecanemab! (No This is Eric Widera. Alex: This is Alex Smith.
105 
Let's personalize your content